Positron emission tomography with 11C-acetate and 18F-FDG in prostate cancer patients
Tóm tắt
Từ khóa
Tài liệu tham khảo
Dennis LK, Resnick MI. Analysis of recent trends in prostate cancer incidence and mortality. Prostate 2000; 42:247–252.
Seltzer MA, Barbaric Z, Belldegrun A, Naitoh J, Dorey F, Phelps ME, Gambhir SS, Hoh CK. Comparison of helical computerized tomography, positron emission tomography and monoclonal antibody scans for evaluation of lymph node metastases in patients with prostate specific antigen relapse after treatment for localized prostate cancer. J Urol 1999; 162:1322–1328.
Hofer C, Laubenbacher C, Block T, Breul J, Hartung R, Schwaiger M. Fluorine-18-fluorodeoxyglucose positron emission tomography is useless for the detection of local recurrence after radical prostatectomy. Eur Urol 1999; 36:31–35.
Kotzerke J, Volkmer B, Neumaier B, Gschwend JE, Hautmann RE, Reske SN. Carbon-11-acetate positron emission tomography can detect local recurrence of prostate cancer. Eur J Nucl Med 2002; 29:1380–1384.
Costello LC, Franklin RB. Citrate metabolism of normal and malignant prostate epithelial cells. Urology 1997; 50:3–12.
Zasadny KR, Wahl RL. Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-d-glucose: variations with body weight and a method for correction. Radiology 1993; 189:847–850.
Meyer GJ, Günther K, Matzke KH, Harms T, Hundeshagen H. A modified preparation method for11C acetate, preventing liquid phase extraction steps. J Labelled Comp Radiopharm 1993; 32:182–183.
Shreve PD, Grossman HB, Gross MD, Wahl RL. Metastatic prostate cancer: initial findings of PET with 2-deoxy-2-[F-18]fluoro-d-glucose. Radiology 1996; 199:751–756.